Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Sydney
About this trial
This trial will investigate the feasibility of the Markerless Tumour Tracking technology.
Eligibility criteria
Qualifiers
Is willing to comply with all trial procedures and intends to provide written Informed Consent for participation in this trial.
Patients undergoing external beam radiotherapy.
Histologically proven Stage I NSCLC or oligometastatic lung metastases (3 or less).
MRI/4D-CT prior to insertion of fiducial markers.
Disqualifiers
Patient has low respiratory performance as evaluated by the physicians.
Previous high-dose thoracic radiotherapy.
Less than one fiducial marker implanted in the lung.
Fiducial markers are too far from the tumour centroid (>9 cm).
Trial design
Treatments tested in this trial
- Markerless Image Guidance
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov